ConditionStomach Neuroendocrine Neoplasm
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAsian Institute of Gastroenterology, India
About this trial
Study objectives:
Primary objective:
1.To determine the histologic R0 resection rate of UEMR for type I gastric NETs measuring 5-9 mm.
Secondary objectives:
To evaluate:
1. En bloc resection rate 2. Immediate and delayed adverse events 3. Procedure time 4. Histologic quality of resection (deep and lateral margins) 5. Residual disease at resection scar on surveillance endoscopy oMetachronous gastric NETs during follow-up
Eligibility criteria
Qualifiers
Age ≥18 years
Fit for endoscopic therapy and sedation
Written informed consent
Disqualifiers
Endoscopically visible gastric neuroendocrine tumor
Size 5-9 mm (endoscopic estimation)
Clinical and/or histologic features consistent with type I gastric NET
No endoscopic features suggestive of deep invasion
Trial design
Treatments tested in this trial
- Endoscopic mucosal resection under water
Treatment groups
60 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov